Health Condition 1: K120- Recurrent oral aphthae
Conditions
Interventions
Intervention1: Habb-e-Qula: 1 Habb/tablet (250 mg) orally twice daily to be chewed for 2-5 min then swallowed. duration of treatment is 10days
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects of either sex in the age group of 18-65 years 2. Subjects with presence of single /multiple ulcers on the non-keratinized mucosa (labial, soft palate, buccal mucosa) With and without any of the following symptoms o Pain or burning sensation o Excessive salivation 2. Subjects with minor Aphthous Ulcers less than 1 cm in diameter
Exclusion criteria
Exclusion criteria: 1. Traumatic ulcers 2. Disorders requiring long term treatment 3. Known cases of underlying systemic diseases such as Crohnâ??s disease, ulcerative colitis, Celiac disease, lupus erythematosus, Behcetâ??s disease, Cyclic neutropenia, immunodeficiency disorders, lichen planus and malignancy 4. Subjects with moderate to severe anemia 5. Known allergy to any component of the test drug. 6. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in sign and symptoms of QulÄ? (Aphthous Ulcer)Timepoint: The patients will be assessed clinically at Day 0, Day 3 , Day 7 and Day 10 | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed